S'abonner

Admission diagnoses among patients with heart failure: Variation by ACO performance on a measure of risk-standardized acute admission rates - 14/12/18

Doi : 10.1016/j.ahj.2018.09.006 
Liliya Benchetrit, BA a, Chloe Zimmerman, BA a, Haikun Bao, PhD b, Kumar Dharmarajan, MD, MBA c, d, Faseeha Altaf, MPH b, Jeph Herrin, PhD d, e, Zhenqiu Lin, PhD b, Harlan M. Krumholz, MD, SM b, d, f, Elizabeth E. Drye, MD, MS b, g, Kasia J. Lipska, MD, MHS b, h, Erica S. Spatz, MD, MHS b, d,
a Yale School of Medicine, New Haven, CT 
b Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 
c Clover Health, Jersey City, NJ 
d Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 
e Health Research & Educational Trust, Chicago, IL 
f Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 
g Department of Pediatrics, Yale University School of Medicine, New Haven, CT 
h Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 

Reprint requests: Erica S. Spatz, MD, MHS, One Church St, Suite 200, New Haven, CT 06510.One Church St, Suite 200New HavenCT06510

Abstract

Background

A key quality metric for Accountable Care Organizations (ACOs) is the rate of hospitalization among patients with heart failure (HF). Among this patient population, non–HF-related hospitalizations account for a substantial proportion of admissions. Understanding the types of admissions and the distribution of admission types across ACOs of varying performance may provide important insights for lowering admission rates.

Methods

We examined admission diagnoses among 220 Medicare Shared Savings Program ACOs in 2013. ACOs were stratified into quartiles by their performance on a measure of unplanned risk-standardized acute admission rates (RSAARs) among patients with HF. Using a previously validated algorithm, we categorized admissions by principal discharge diagnosis into: HF, cardiovascular/non-HF, and noncardiovascular. We compared the mean admission rates by admission type as well as the proportion of admission types across RSAAR quartiles (Q1-Q4).

Results

Among 220 ACOs caring for 227,356 patients with HF, the median (IQR) RSAARs per 100 person-years ranged from 64.5 (61.7-67.7) in Q1 (best performers) to 94.0 (90.1-99.9) in Q4 (worst performers). The mean admission rates by admission types for ACOs in Q1 compared with Q4 were as follows: HF admissions: 9.8 (2.2) vs 14.6 (2.8) per 100 person years (P < .0001); cardiovascular/non-HF admissions: 11.1 (1.6) vs 15.9 (2.6) per 100 person-years (P < .0001); and noncardiovascular admissions: 42.7 (5.4) vs 69.6 (11.3) per 100 person-years (P < .0001). The proportion of admission due to HF, cardiovascular/non-HF, and noncardiovascular conditions was 15.4%, 17.5%, and 67.1% in Q1 compared with 14.6%, 15.9%, and 69.4% in Q4 (P < .007).

Conclusions

Although ACOs with the best performance on a measure of all-cause admission rates among people with HF tended to have fewer admissions for HF, cardiovascular/non-HF, and noncardiovascular conditions compared with ACOs with the worst performance (highest admission rates), the largest difference in admission rates were for noncardiovascular admission types. Across all ACOs, two-thirds of admissions of patients with HF were for noncardiovascular causes. These findings suggest that comprehensive approaches are needed to reduce the diverse admission types for which HF patients are at risk.

Le texte complet de cet article est disponible en PDF.

Plan


 Conflict of Interest: Authors H. B., K. D., K. L., E. D., J. H., H. M. K., and E. S. S. work under contract with the Centers for Medicare and Medicaid Services to develop and maintain performance measures. The Centers for Medicare and Medicaid Services had no role in the study design; in the collection, analysis, and interpretation of data; or in the writing of the report.


© 2018  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 207

P. 19-26 - janvier 2019 Retour au numéro
Article précédent Article précédent
  • Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention : Results from a large single-center prospective registry
  • Paul Guedeney, Usman Baber, Bimmer Claessen, Melissa Aquino, Anton Camaj, Sabato Sorrentino, Birgit Vogel, Serdar Farhan, Michela Faggioni, Jaya Chandrasekhar, Deborah N. Kalkman, Jason C. Kovacic, Joseph Sweeny, Nitin Barman, Pedro Moreno, Pooja Vijay, Srushthi Shah, George Dangas, Annapoorna Kini, Samin Sharma, Roxana Mehran
| Article suivant Article suivant
  • System-integrated technology-enabled model of care to improve the health of stroke patients in rural China: protocol for SINEMA—a cluster-randomized controlled trial
  • Enying Gong, Wanbing Gu, Cheng Sun, Elizabeth L. Turner, Yun Zhou, Zixiao Li, Janet Prvu Bettger, Brian Oldenburg, Alba Amaya-Burns, Yilong Wang, Li-Qun Xu, Jianmin Yao, Dejin Dong, Zhenli Xu, Chaoyun Li, Mobai Hou, Lijing L. Yan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.